| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |